Completed
Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS
NCT03066648
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +15 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Oregon Health Sciences University Main Center Portland, Oregon, United States
- MD Anderson Cancer Center Houston, Texas, United States
- Novartis Investigative Site Melbourne, Victoria, Australia